PR Newswire Clinical TrialsOriginal article
Nitinotes Announces Weill Cornell Medicine and NewYork-Presbyterian/Weill Cornell Medical Center Clinical Site Activation in the EASE™ IDE Trial
Trial StartEndoZip™ Automated Suturing SystemPositive
AI Analysis
Summary
Nitinotes announced activation of Weill Cornell Medicine as a clinical site in the EASE IDE Trial for its EndoZip Automated Suturing System, with the first patient treated by Dr. Reem Sharaiha for endoscopic sleeve gastroplasty.
Clinical Trial Data
Patients
1
Outcome Details
First study patient treated in EASE IDE Trial
Importance:4/10
Sentiment:
0.40
Clinical TrialMedical DeviceSite ActivationEndoZipESG
Read the original article
Published by PR Newswire Clinical Trials on August 11, 2026 1:30 PM